BRAF c.1823A>T ;(p.H608L)

Variant ID: 7-140453112-T-A

NM_004333.4(BRAF):c.1823A>T;(p.H608L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.

Nature Genetics
Kar, Siddhartha P SP; Quiros, Pedro M PM; Gu, Muxin M; Jiang, Tao T; Mitchell, Jonathan J; Langdon, Ryan R; Iyer, Vivek V; Barcena, Clea C; Vijayabaskar, M S MS; Fabre, Margarete A MA; Carter, Paul P; Petrovski, Slavé S; Burgess, Stephen S; Vassiliou, George S GS
Publication Date: 2022-08

Variant appearance in text: BRAF: H608L
PubMed Link: 35835912
Variant Present in the following documents:
  • 41588_2022_1121_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.

Molecular Systems Biology
Kiel, Christina C; Serrano, Luis L
Publication Date: 2014-05-06

Variant appearance in text: BRAF: H608L
PubMed Link: 24803665
Variant Present in the following documents:
  • MSB-10-5-727-s13.xls, sheet 1
View BVdb publication page



Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways.

Molecular Cancer
Pignochino, Ymera Y; Grignani, Giovanni G; Cavalloni, Giuliana G; Motta, Manuela M; Tapparo, Marta M; Bruno, Stefania S; Bottos, Alessia A; Gammaitoni, Loretta L; Migliardi, Giorgia G; Camussi, Giovanni G; Alberghini, Marco M; Torchio, Bruno B; Ferrari, Stefano S; Bussolino, Federico F; Fagioli, Franca F; Picci, Piero P; Aglietta, Massimo M
Publication Date: 2009-12-10

Variant appearance in text: BRAF: H608L
PubMed Link: 20003259
Variant Present in the following documents:
  • Main text
  • 1476-4598-8-118.pdf
View BVdb publication page